© 2022 MJH Life Sciences and GeneTherapyLive™. All rights reserved.
© 2022 MJH Life Sciences™ and GeneTherapyLive™. All rights reserved.
Further details on the KEYNOTE-B79 trial were presented at the 2022 ASCO GI Symposium.
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in gene and cell therapies.
The phase 1/2 ARYA-2 trial will be run in parallel with the similar phase 1/2 ARYA-1 and ARYA-3 trials.